Therefore, STIM1 overexpression and STIM1-related molecular signatures were tightly correlated with COAD patient prognoses, and this phenomenon was enormously significant especially in the STIM1 overexpression group versus the STIM1 low-expression group. Here, STIM1 is linked to colon adenocarcinoma.